Armistice Capital’s BriaCell Therapeutics Corp. Warrant BCTXW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.88K | Hold |
25,000
| – | – | ﹤0.01% | 196 |
|
2025
Q1 | $2.55K | Sell |
25,000
-350,000
| -93% | -$35.7K | ﹤0.01% | 216 |
|
2024
Q4 | $109K | Hold |
375,000
| – | – | ﹤0.01% | 199 |
|
2024
Q3 | $154K | Hold |
375,000
| – | – | ﹤0.01% | 222 |
|
2024
Q2 | $101K | Hold |
375,000
| – | – | ﹤0.01% | 218 |
|
2024
Q1 | $510K | Hold |
375,000
| – | – | 0.01% | 194 |
|
2023
Q4 | $938K | Hold |
375,000
| – | – | 0.01% | 174 |
|
2023
Q3 | $926K | Hold |
375,000
| – | – | 0.01% | 143 |
|
2023
Q2 | $938K | Sell |
375,000
-1
| -0% | -$3 | 0.01% | 158 |
|
2023
Q1 | $1.11M | Buy |
375,001
+1
| +0% | +$3 | 0.02% | 132 |
|
2022
Q4 | $772K | Hold |
375,000
| – | – | 0.01% | 135 |
|
2022
Q3 | $1.08M | Hold |
375,000
| – | – | 0.02% | 134 |
|
2022
Q2 | $975 | Hold |
375,000
| – | – | 0.02% | 127 |
|
2022
Q1 | $1.95M | Hold |
375,000
| – | – | 0.04% | 98 |
|
2021
Q4 | $1.76M | Hold |
375,000
| – | – | 0.03% | 121 |
|
2021
Q3 | $1.78M | Hold |
375,000
| – | – | 0.03% | 115 |
|
2021
Q2 | $675K | Sell |
375,000
-45,536
| -11% | -$82K | 0.01% | 109 |
|
2021
Q1 | $450K | Buy |
+420,536
| New | +$450K | 0.01% | 106 |
|